Levina

Ethinylestradiol and Levonorgestrel, the active ingredients in Levina, are a combined oral contraceptive presented as tablets for oral use. This hormonal formulation works to prevent pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the endometrium, and is indicated for use by women of reproductive age seeking reliable birth control. It provides a convenient once‑daily dosing schedule and is part of a well‑established class of estrogen‑progestin contraceptives that have been used worldwide for decades.

GNH USA supplies Levina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levina, a combined oral contraceptive, is used to prevent pregnancy.

Contraception: prevents pregnancy in women of reproductive age. Family planning: provides a reliable method for planned childbearing. Menstrual regulation: helps achieve more predictable menstrual cycles.

Levina may cause a range of adverse reactions. Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional tension‑type headaches. - Spotting: irregular bleeding between periods. Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in leg veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke or myocardial infarction: rare cardiovascular events. - Severe allergic reaction: rash, swelling, or breathing difficulty. - Liver tumor: very rare hepatic adenoma.

Before prescribing Levina, clinicians should consider several safety aspects.

Contraindications: avoid in women with a history of thromboembolic disorders. Smoking: do not use in patients over 35 who smoke cigarettes. Medication review: assess concurrent use of enzyme‑inducing drugs. Pregnancy: discontinue immediately if pregnancy is confirmed. Store at ambient temperature: keep in the original pack, protect from moisture.

Levina can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin): may reduce contraceptive efficacy. - Certain antiretrovirals (e.g., efavirenz): can lower hormone levels. - St. John’s wort: may compromise birth control reliability. Moderate Interactions (Monitor Closely): - Antifungal agents (ketoconazole, itraconazole): may increase hormone concentrations. - Antibiotics (rifabutin, griseofulvin): potential modest reduction in effectiveness. - Anticonvulsants (valproate): may require additional contraceptive measures.